top of page
IMG_4056_ua.jpg

PUBLISHED WORK

NON-HOST FACTORS INFLUENCING ONSET AND SEVERITY OF CELIAC DISEASE

GASTROENTEROLOGY

January, 2024

Galipeau HJ, Hinterleitner R, Leonard MM, Caminero A

August, 2023

Medina Sanchez L, Siller M, Zeng Y, Brigleb PH, Sangani KA, Soto AS, Engl C, Laughlin CR, Rana M, Van Der Kraak L, Pandey SP, Bender MJ, Fitzgerald B, Hedden L, Fiske K, Taylor GM, Wright AP, Mehta ID, Rahman SA, Galipeau HJ, Mullett SJ, Gelhaus SL, Watkins SC, Bercik P, Nice TJ, Jabri B, Meisel M, Das J, Dermody TS, Verdú EF, Hinterleitner R.

DIETARY TRYPTOPHAN METABOLITE RELEASED BY INTRATUMORAL LACTOBACILLUS REUTERI FACILITATES IMMUNE CHECKPOINT INHIBITOR THERAPY
​
CELL

April, 2023

Bender MJ#, McPherson AC#, Phelps CM, Pandey SP, Laughlin CR, Shapira JK, Medina Sanchez L, Rana M, Richie TG, Mims TS, Gotcher-Demske AM, Cervantes-Barragan L, Mullett SJ, Gelhaus SL, Bruno TC, Cannon N, McCulloch JA, Vignali DAA, Hinterleitner R, Joglekar AV, Pierre JF, Lee STM, Davor D, , Zarour HM, Meisel M

NK CELLS CONTRIBUTE TO REOVIRUS-INDUCED IFN RESPONSES AND LOSS OF TOLERANCE TO DIETARY ANTIGEN

​

JCI INSIGHT

August, 2022

Brigleb PH, Kouame E, Fiske KL, Taylor GM, Urbanek K, Medina Sanchez L, Hinterleitner R, Jabri B, Dermody TS.

TET2 DEFICIENCY DRIVES LIVER MICROBIOME DYSBIOSIS TRIGGERING TC1 CELL AUTOIMMUNE HEPATITIS

​

CELL HOST MICROBE

July, 2022

Pandey SP, Bender MJ, McPherson AC, Phelps CM, Sanchez LM, Rana M, Hedden L, Sangani KA, Chen L, Shapira JH, Siller M, Goel C, Verdú EF, Jabri B, Chang A, Chandran UR, Mullett SJ, Wendell SG, Singhi AD, Tilstra JS, Pierre JF, Arteel GE, Hinterleitner R, Meisel M.

CAN MICROBES BOOST TREGS TO SUPPRESS FOOD SENSITIVITIES?

​

TRENDS IN IMMUNOLOGY

October, 2020

Siller M, Zeng Y, Hinterleitner R.

HIGH-SENSITIVITY C-REACTIVE PROTEIN IS ASSOCIATED WITH CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL

​

BLOOD ADVANCES

June, 2020

Busque L, Sun M, Buscarlet M, Ayachi S, Feroz Zada Y, Provost S, Bourgoin V, Mollica L, Meisel M, Hinterleitner R, Jabri B, Dubé MP, Tardif JC.

MURINE NOROVIRUS INFECTION INDUCES TH1 INFLAMMATORY RESPONSES TO DIETARY ANTIGENS

​

CELL HOST MICROBE

November, 2018

Bouziat R, Biering SB, Kouame E, Sangani KA, Kang S, Ernest JD, Varma M, Brown JJ, Urbanek K, Dermody TS, Ng A, Hinterleitner R, Hwang S#, Jabri B#; #contributed equally

REGULATION OF LYMPHATIC GM-CSF EXPRESSION BY THE E3 UBIQUITIN LIGASE CBL-B

​

FRONTIERS IN IMMUNOLOGY

October, 2018

Peer S, Cappellano G, Hermann-Kleiter N, Albrecht-Schgoer K, Hinterleitner R, Baier G#, Gruber T#; #contributed equally

MITOCHONDRIA MAINTAIN CONTROLLED ACTIVATION STATE OF EPITHELIAL-RESIDENT T LYMPHOCYTES.

​

SCIENCE IMMUNOLOGY

Juni, 2018

Konjar Å #, Frising UC#, Ferreira C, Hinterleitner R, Mayassi T, Zhang Q, Blankenhaus B, Haberman N, Loo Y, Guedes J,
Baptista M, Innocentin S, Stange J, Strathdee D, Jabri B, Veldhoen M.  #contributed equally

MICROBIAL SIGNALS DRIVE TET2-MEDIATED PRE-LEUKEMIC MYELOPROLIFERATION.

​

NATURE

May, 2018

Meisel M#, Hinterleitner R#, Pacis A, Buscarlet M, Chen L, Pierre J, Bouziat R, Ernest J, Ringus D, GalipeauH, Armstrong S, McDonald B, Zurenski M, Musch M, Furtado G, Lira S,Chang E, E. Verdu, Godley L, Busque L, Barreiro L and Jabri B; #contributed equally

REOVIRUS INFECTION BREAKS TOLERANCE TO DIETARY ANTIGENS AND PROMOTES DEVELOPMENT OF CELIAC DISEASE.


SCIENCE

April, 2017

Bouziat R#,Hinterleitner R#, Brown JJ#, Stencel-Baerenwald JE, Ikizler M, Mayassi T, MeiselM, Kim SM, Discepolo V, PruijssersAJ, ErnestJD, IskarpatyotiJA, CostesLMM, Lawrence I, Palanski BA, Varma M, ZurenskiMA, Khomandiak S, McAllister N, AravamudhanP, BoehmeKW, Hu F, Samsom JN, Reinecker HC, Kupfer SS, Guandalini S, Semrad C, Abadie V, Khosla C, Barreiro LB, Xavier RJ, Ng A, Dermody TS, Jabri B; #contributed equally

ANTIBIOTIC-INDUCED PERTURBATIONS IN MICROBIAL DIVERSITY DURING DEVELOPMENT ALTERS AMYLOID PATHOLOGY IN APPSWE/PS1ΔE9 MURINE MODEL OF ALZHEIMER’S DISEASE.


SCIENTIFIC REPORTS

September, 2017

Minter MR, Meisel M#, Hinterleitner#, Zhang C#, Leone V, Zhang X, Oyler-Castrillo P, Musch MW, Jabri B, Chang EB, Tanzi RE, Sisodia SS; #contributed equally

DIETARY ANTIOXIDANT MICRONUTRIENTS ALTER MUCOSAL INFLAMMATORY RISK IN A MURINE MODEL OF GENETIC AND MICROBIAL SUSCEPTIBILITY.

​

THE JOURNAL OF NUTRITIONAL BIOCHEMISTRY

December, 2017

Pierre JF, Hinterleitner R, Bouziat R, Hubert NA, Leone V, Miyoshi J, Jabri B, Chang EB

INTERLEUKIN-15 PROMOTES INTESTINAL DYSBIOSIS WITH BUTYRATE DEFICIENCY ASSOCIATED WITH INCREASED SUSCEPTIBILITY TO COLITIS.

​

ISME

January, 2017

Meisel M, Mayassi T, Fehlner-Peach H, Koval JC, O'Brien SL, Hinterleitner R, Lesko K, Kim S, Bouziat R, Chen L, Weber CR, Mazmanian SK, Jabri B, Antonopoulos DA.

A DENDRITIC CELL SUBSET DESIGNED FOR ORAL TOLERANCE.

​

NATURE IMMUNOLOGY

April, 2016

Hinterleitner R, Jabri B

THE E3 LIGASE CBL-B AND TAM RECEPTORS REGULATE CANCER METASTASIS VIA NATURAL KILLER CELLS.

​

NATURE

March, 2014

Paolino M, Choidas A, Wallner S, Pranjic B, Uribesalgo I, Loeser S, Jamieson AM, Langdon WY, Ikeda F, Fededa JP, Cronin SJ, Nitsch R, Schultz-Fademrecht C, Eickhoff J, Menninger S, Unger A, Torka R, Gruber T, Hinterleitner R, Baier G, Wolf D, Ullrich A, Klebl BM, Penninger JM.

CBL-B MEDIATES TGFÎ’ SENSITIVITY BY DOWNREGULATION OF THE INHIBITORY SMAD7 IN PRIMARY T CELLS.

​

JOURNAL OF MOLECULAR CELL BIOLOGY

December, 2013

Hinterleitner R#, Gruber T#, Hermann-Kleiter N, Meisel M, Pfeifhofer-Obermair C, Kleiter I, Wang M, Viola A, Baier G; # contributed equally

ENGINEERING EFFECTIVE T-CELL BASED ANTITUMOR IMMUNITY.

​

ONCOIMMUNOLOGY

February, 2013

Gruber T, Hinterleitner R, Pfeifhofer-Obermair C, Wolf D, Baier G. Engineering effective T-cell based antitumor immunity.
Oncoimmunology 2013 Feb 1;2(2):e22893.

THE KINASE PKCΑ SELECTIVELY UPREGULATES INTERLEUKIN-17A DURING TH17 CELL IMMUNE RESPONSES

​

IMMUNITY

January, 2013

Meisel M, Hermann-Kleiter N, Hinterleitner R, Gruber T, Wachowicz K, Pfeifhofer-Obermair C, Fresser F, Leitges M, Soldani C, Viola A, Kaminski S, Baier G.

ADOPTIVE TRANSFER OF SIRNA CBLB-SILENCED CD8+ T LYMPHOCYTES AUGMENTS TUMOR VACCINE EFFICACY IN A B16 MELANOMA MODEL.


PLOS ONE

September, 2012

Hinterleitner R#, Gruber T#, Pfeifhofer-Obermair C#, Lutz-Nicoladoni C#, Tzankov A, Schuster M, Penninger JM, Loibner H,
Lametschwandtner G, Wolf D, Baier G. # contributed equally

February, 2011

bottom of page